Results 71 to 80 of about 5,639 (136)

Pediatric Pulmonary Hypertension Associated With Treatment of Myeloproliferative Disorders and Malignant Tumors

open access: yesPulmonary Circulation
Pulmonary hypertension (PH) is a severe complication observed in pediatric patients after hematopoietic cell transplantation or chemotherapy. A review of records at Hokkaido University Hospital (2014–2024) identified four cases of PH, each with different
Ayako Chida‐Nagai   +5 more
doaj   +1 more source

Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease

open access: yes, 2019
International audienceHepatic veno-occlusive disease (HVOD), alias sinusoidal obstruction syndrome, may develop as a complication of chemotherapy in the setting of hematopoietic stem cell transplantation.
Günther, Sven   +11 more
core   +1 more source

Pulmonary Vascular Occlusive Disease Presenting as Sudden Death

open access: yes, 1990
We report a case of pulmonary vascular occlusive disease (also termed pulmonary veno occlusive disease) which caused the sudden death of an eleven-year-old girl.
M. A. Bolster, C.P. Bredin, J. Hogan
core   +1 more source

The chest CT signs for pulmonary veno-occlusive disease correlate with pulmonary haemodynamics in systemic sclerosis

open access: yes, 2023
Objectives Pulmonary arterial hypertension associated with systemic sclerosis (PAH-SSc) sometimes accompanies pulmonary veno-occlusive disease (PVOD).
Ryo Hisada   +27 more
core   +1 more source

EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension

open access: yes, 2014
International audiencePulmonary veno-occlusive disease (PVOD) is a rare and devastating cause of pulmonary hypertension that is characterized histologically by widespread fibrous intimal proliferation of septal veins and preseptal venules and is ...
Barbara Girerd   +31 more
core   +1 more source

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications

open access: yesPulmonary Circulation, 2019
Diagnostic World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) and Diagnostic Group 1' pulmonary veno-occlusive disease (PVOD) and/or pulmonary capillary hemangiomatosis (PCH) are progressive and fatal disorders. Past registries
C. Gregory Elliott   +13 more
doaj   +1 more source

Supplementary Material for: Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation

open access: yes, 2023
Pulmonary veno-occlusive disease (PVOD) is an extremely rare condition in oncology practice. Although PVOD is clinically similar to pulmonary arterial hypertension, the conditions differ in terms of pathophysiology, management, and prognosis. This report
Odum E.P.1 , Asekomeh E.G.2 , Ntuen N.A. 3 , Young E.E.4 (661554)   +14 more
core   +1 more source

Heritable pulmonary hypertension: from bench to bedside

open access: yesEuropean Respiratory Review, 2017
Mutations in the BMPR2 gene, and more rarely in ACVRL1, endoglin, caveolin-1, KCNK3 and TBX4 genes predispose to heritable pulmonary arterial hypertension, an autosomal dominant disease with incomplete penetrance. Bi-allelic mutations in the EIF2AK4 gene
Barbara Girerd   +3 more
doaj   +1 more source

Comprehensive three‐dimensional morphology of neoangiogenesis in pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis

open access: yesThe Journal of Pathology: Clinical Research, 2019
Pulmonary veno‐occlusive disease (PVOD) is a rare lung disease characterized by fibrotic narrowing of pulmonary veins leading to pulmonary hypertension (PH) and finally to death by right heart failure.
Lavinia Neubert   +12 more
doaj   +1 more source

Resolution of Pulmonary Hypertension with Low-Molecular-Weight Heparin, Steroid, and Prostacyclin Analogue Therapy: Could it be Early-Phase Pulmonary Veno-Occlusive Disease?

open access: yes, 2011
Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension. The authors present a case of neuroblastoma with progressive dyspnea, hypoxemia, and pulmonary hypertension.
Zuhal Keskin Yildirim   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy